Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Diagnostic accuracy for macroscopic classification of nodular hepatocellular carcinoma: comparison of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and angiography-assisted computed tomography.

Tada T, Kumada T, Toyoda H, Ito T, Sone Y, Okuda S, Ogawa S, Igura T, Imai Y.

J Gastroenterol. 2015 Jan;50(1):85-94. doi: 10.1007/s00535-014-0947-x. Epub 2014 Feb 22.

PMID:
24563123
2.

Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma.

Iwamoto T, Imai Y, Kogita S, Igura T, Sawai Y, Fukuda K, Yamaguchi Y, Matsumoto Y, Nakahara M, Morimoto O, Seki Y, Ohashi H, Fujita N, Kudo M, Takehara T.

Dig Dis. 2016;34(6):679-686. Epub 2016 Oct 17.

PMID:
27750237
3.

Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinoma.

Kobayashi T, Aikata H, Hatooka M, Morio K, Morio R, Kan H, Fujino H, Fukuhara T, Masaki K, Ohno A, Naeshiro N, Nakahara T, Honda Y, Murakami E, Kawaoka T, Tsuge M, Hiramatsu A, Imamura M, Kawakami Y, Hyogo H, Takahashi S, Chayama K.

Eur Radiol. 2015 Nov;25(11):3272-81. doi: 10.1007/s00330-015-3725-0. Epub 2015 Jun 3.

PMID:
26037713
4.

Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT.

Inoue T, Kudo M, Komuta M, Hayaishi S, Ueda T, Takita M, Kitai S, Hatanaka K, Yada N, Hagiwara S, Chung H, Sakurai T, Ueshima K, Sakamoto M, Maenishi O, Hyodo T, Okada M, Kumano S, Murakami T.

J Gastroenterol. 2012 Sep;47(9):1036-47. doi: 10.1007/s00535-012-0571-6. Epub 2012 Apr 17.

PMID:
22526270
5.

Contrast-enhanced computed tomography plus gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging for gross classification of hepatocellular carcinoma.

Chen C, Zhao H, Fu X, Huang L, Tang M, Yan X, Sun S, Jia W, Mao L, Shi J, Chen J, He J, Zhu J, Qiu Y.

Oncotarget. 2017 May 2;8(18):29741-29750. doi: 10.18632/oncotarget.15712.

6.

Therapy response assessment after radioembolization of patients with hepatocellular carcinoma--comparison of MR imaging with gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid and gadobutrol.

Schelhorn J, Best J, Reinboldt MP, Gerken G, Ruhlmann M, Lauenstein TC, Antoch G, Kinner S.

J Vasc Interv Radiol. 2015 Jul;26(7):972-9. doi: 10.1016/j.jvir.2015.03.009. Epub 2015 Apr 27.

PMID:
25937296
7.

Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.

Donati OF, Hany TF, Reiner CS, von Schulthess GK, Marincek B, Seifert B, Weishaupt D.

J Nucl Med. 2010 May;51(5):692-9. doi: 10.2967/jnumed.109.068510. Epub 2010 Apr 15.

9.

Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.

Kim HY, Choi JY, Kim CW, Bae SH, Yoon SK, Lee YJ, Rha SE, You YK, Kim DG, Jung ES.

Liver Transpl. 2012 Jul;18(7):850-7. doi: 10.1002/lt.23426.

10.

Diagnostic sensitivity of imaging modalities for hepatocellular carcinoma smaller than 2 cm.

Mita K, Kim SR, Kudo M, Imoto S, Nakajima T, Ando K, Fukuda K, Matsuoka T, Maekawa Y, Hayashi Y.

World J Gastroenterol. 2010 Sep 7;16(33):4187-92.

11.

Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT.

Akai H, Kiryu S, Matsuda I, Satou J, Takao H, Tajima T, Watanabe Y, Imamura H, Kokudo N, Akahane M, Ohtomo K.

Eur J Radiol. 2011 Nov;80(2):310-5. doi: 10.1016/j.ejrad.2010.07.026. Epub 2010 Aug 21.

PMID:
20732773
12.

Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.

Tateyama A, Fukukura Y, Takumi K, Shindo T, Kumagae Y, Kamimura K, Nakajo M.

World J Gastroenterol. 2012 Nov 21;18(43):6269-76. doi: 10.3748/wjg.v18.i43.6269.

13.
14.

Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC.

Toyoda H, Kumada T, Tada T, Sone Y, Maeda A, Kaneoka Y.

Hepatol Int. 2015 Jan;9(1):84-92. doi: 10.1007/s12072-014-9553-5. Epub 2014 Jul 23.

PMID:
25788383
15.

HCC-to-liver contrast on arterial-dominant phase images of EOB-enhanced MRI: comparison with dynamic CT.

Kanata N, Yoshikawa T, Ohno Y, Kanda T, Uchida K, Izaki K, Fukumoto T, Ku Y, Itoh T, Kitajima K, Takahashi S, Sugimura K.

Magn Reson Imaging. 2013 Jan;31(1):17-22. doi: 10.1016/j.mri.2012.06.012. Epub 2012 Aug 13.

PMID:
22898685
16.

Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with Gd-EOB-DTPA to detect small hepatocellular carcinoma.

Kunishi Y, Numata K, Morimoto M, Okada M, Kaneko T, Maeda S, Tanaka K.

AJR Am J Roentgenol. 2012 Jan;198(1):106-14. doi: 10.2214/AJR.10.6039.

PMID:
22194485
17.

Clinicopathological significance of the peritumoral decreased uptake area of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid in hepatocellular carcinoma.

Nishie A, Asayama Y, Ishigami K, Kakihara D, Nakayama T, Ushijima Y, Takayama Y, Shirabe K, Fujita N, Kubo Y, Hirakawa M, Honda H.

J Gastroenterol Hepatol. 2014 Mar;29(3):561-7. doi: 10.1111/jgh.12423.

PMID:
24219648
18.

Using low tube voltage (80kVp) quadruple phase liver CT for the detection of hepatocellular carcinoma: two-year experience and comparison with Gd-EOB-DTPA enhanced liver MRI.

Lee CH, Kim KA, Lee J, Park YS, Choi JW, Park CM.

Eur J Radiol. 2012 Apr;81(4):e605-11. doi: 10.1016/j.ejrad.2011.12.033. Epub 2012 Jan 31.

PMID:
22297180
19.

Health economic evaluation of Gd-EOB-DTPA MRI vs ECCM-MRI and multi-detector computed tomography in patients with suspected hepatocellular carcinoma in Thailand and South Korea.

Lee JM, Kim MJ, Phongkitkarun S, Sobhonslidsuk A, Holtorf AP, Rinde H, Bergmann K.

J Med Econ. 2016 Aug;19(8):759-68. doi: 10.3111/13696998.2016.1171230. Epub 2016 Apr 27.

PMID:
27026278
20.

Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.

Lee S, Kim SH, Park CK, Kim YS, Lee WJ, Lim HK.

J Magn Reson Imaging. 2010 Sep;32(3):719-25. doi: 10.1002/jmri.22291.

PMID:
20815073

Supplemental Content

Support Center